ImmunoGen Inc (NASDAQ:IMGN)

6.17
Data as of Jan 28
 -0.26 / -4.04%
Today’s Change
5.34
Today|||52-Week Range
17.80
+1.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues30.1M6.9M5.7M13.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
Total Operating Expenses26.3M44.3M32.2M35.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.8M-37.4M-26.5M-21.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.8M-37.5M-26.5M-22.3M
 
 
 
 
 
Net Income3.8M-37.5M-26.5M-22.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.4M85.7M85.8M85.9M
 
 
 
 
 
Shares To Calculate EPS Diluted87.3M85.7M85.8M85.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04-$0.44-$0.31-$0.26
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.